Lucid Diagnostics Inc

NASDAQ:LUCD 4:00:00 PM EDT

0.82

+0.01 (+0.76%)

6:35:37 PM EDT: $0.82 0.00 (-0.12%)

Market Cap (Intraday)	44.54M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.14 Million
Adjusted EPS	-$0.20

See more estimates

10-Day MA	$0.83
50-Day MA	$0.82
200-Day MA	$1.03

See more pivots

Lucid Diagnostics Inc Stock, NASDAQ:LUCD

360 Madison Avenue, 25th Floor, New York, New York 10017

United States of America

Phone: +1.212.949.4319

Number of Employees: 70

http://www.luciddx.com

Description

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.